Page last updated: 2024-08-23

quinpirole and bp 897

quinpirole has been researched along with bp 897 in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's8 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bettinetti, L; Gmeiner, P; Hübner, H; Schlotter, K1
Aiello, F; Butini, S; Cagnotto, A; Campiani, G; Carnovali, F; Catalanotti, B; Cervo, L; Fattorusso, C; Fumagalli, E; Gemma, S; Mennini, T; Nacci, V; Novellino, E; Stark, JA; Trotta, F1
Berardi, F; Colabufo, NA; Contino, M; Lacivita, E; Leopoldo, M; Perrone, R1
Boeckler, F; Gmeiner, P; Hübner, H; Schlotter, K1
Berardi, F; Contino, M; De Giorgio, P; Lacivita, E; Leopoldo, M; Perrone, R1
Avenell, KY; Boyfield, I; Jewitt, FR; Nash, DJ; Riley, GJ; Wood, MD1
Garcia-Ladona, J; Wicke, K1
Beardsley, PM; Cook, CD; Newman, JL; Winfree, JC1

Other Studies

8 other study(ies) available for quinpirole and bp 897

ArticleYear
Interactive SAR studies: rational discovery of super-potent and highly selective dopamine D3 receptor antagonists and partial agonists.
    Journal of medicinal chemistry, 2002, Oct-10, Volume: 45, Issue:21

    Topics: Animals; CHO Cells; Cricetinae; Dopamine Agonists; Dopamine Antagonists; Humans; Ligands; Mitosis; Piperazines; Radioligand Assay; Receptors, Dopamine D2; Receptors, Dopamine D3; Structure-Activity Relationship; Swine; Thiophenes

2002
Synthesis and pharmacological evaluation of potent and highly selective D3 receptor ligands: inhibition of cocaine-seeking behavior and the role of dopamine D3/D2 receptors.
    Journal of medicinal chemistry, 2003, Aug-28, Volume: 46, Issue:18

    Topics: Animals; Behavior, Addictive; Brain; Cocaine; Cocaine-Related Disorders; Conditioning, Operant; Dopamine Agonists; Dopamine Antagonists; Extinction, Psychological; In Vitro Techniques; Ligands; Male; Models, Molecular; Piperazines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Self Administration; Structure-Activity Relationship

2003
First structure-activity relationship study on dopamine D3 receptor agents with N-[4-(4-arylpiperazin-1-yl)butyl]arylcarboxamide structure.
    Journal of medicinal chemistry, 2005, Dec-15, Volume: 48, Issue:25

    Topics: Amides; Animals; CHO Cells; Cricetinae; Cricetulus; Humans; Piperazines; Radioligand Assay; Receptors, Dopamine D3; Stereoisomerism; Structure-Activity Relationship

2005
Fancy bioisosteres: novel paracyclophane derivatives as super-affinity dopamine D3 receptor antagonists.
    Journal of medicinal chemistry, 2006, Jun-15, Volume: 49, Issue:12

    Topics: Amides; Animals; Benzene Derivatives; Benzofurans; Binding Sites; Bridged-Ring Compounds; Central Nervous System Agents; CHO Cells; Corpus Striatum; Cricetinae; Cricetulus; Humans; In Vitro Techniques; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Conformation; Mutation; Radioligand Assay; Receptors, Dopamine D3; Stereoisomerism; Structure-Activity Relationship; Swine; Thymidine

2006
Design, synthesis, and binding affinities of potential positron emission tomography (PET) ligands with optimal lipophilicity for brain imaging of the dopamine D3 receptor. Part II.
    Bioorganic & medicinal chemistry, 2009, Jan-15, Volume: 17, Issue:2

    Topics: Amides; Drug Design; Humans; Ligands; Piperazines; Positron-Emission Tomography; Protein Binding; Radiopharmaceuticals; Receptors, Dopamine D3

2009
Evidence for antagonist activity of the dopamine D3 receptor partial agonist, BP 897, at human dopamine D3 receptor.
    European journal of pharmacology, 2000, Oct-27, Volume: 407, Issue:1-2

    Topics: Animals; Azepines; CHO Cells; Cricetinae; Dopamine Agonists; Humans; Piperazines; Quinpirole; Receptors, Dopamine D2; Receptors, Dopamine D3

2000
The dopamine D3 receptor partial agonist, BP 897, is an antagonist at human dopamine D3 receptors and at rat somatodendritic dopamine D3 receptors.
    European journal of pharmacology, 2001, Jul-20, Volume: 424, Issue:2

    Topics: Animals; Benzopyrans; Binding, Competitive; CHO Cells; Cricetinae; Dendrites; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Electrophysiology; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Male; Neurons; Oxazines; Piperazines; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Substantia Nigra; Sulfur Radioisotopes; Tetrahydronaphthalenes

2001
Modulation of the locomotor activating effects of the noncompetitive NMDA receptor antagonist MK801 by dopamine D2/3 receptor agonists in mice.
    Pharmacology, biochemistry, and behavior, 2004, Volume: 77, Issue:2

    Topics: Animals; Dizocilpine Maleate; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Male; Mice; Motor Activity; Naphthalenes; Piperazines; Pyrrolidines; Quinolines; Quinpirole; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, N-Methyl-D-Aspartate; Salicylamides; Stereotyped Behavior

2004
chemdatabank.com